Open Access

[Corrigendum] Targeting cysteine‑rich angiogenic inducer‑61 by antibody immunotherapy suppresses growth and migration of non‑small cell lung cancer

  • Authors:
    • Xinpeng Li
    • Naxin Yuan
    • Lingdan Lin
    • Lixia Yin
    • Yiqing Qu
  • View Affiliations

  • Published online on: May 11, 2022     https://doi.org/10.3892/etm.2022.11365
  • Article Number: 438
  • Copyright : © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Exp Ther Med 16:[Related article:] 730–738, 2018; DOI: 10.3892/etm.2018.6274

Following the publication of this paper, it was drawn to the attention of the Editorial Office by a concerned reader that the western blots featured in Fig. 4C and E on p. 736 appeared to have been misplaced, or were possibly mislabelled. After having asked the authors for an explanation to account for the problematic appearance of this figure, they realized that errors were made during the compilation of this figure, and supplied a new version of this figure to the office containing new data which rectifies the problems that were identified. The new version of Fig. 4 is shown below. All the authors agree with the publication of this corrigendum, and thank the Editor of Experimental and Therapeutic Medicine for allowing them the opportunity to publish this. Furthermore, they apologize to the readership for any inconvenience caused.

Related Articles

Journal Cover

July-2022
Volume 24 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li X, Yuan N, Lin L, Yin L and Qu Y: [Corrigendum] Targeting cysteine‑rich angiogenic inducer‑61 by antibody immunotherapy suppresses growth and migration of non‑small cell lung cancer. Exp Ther Med 24: 438, 2022
APA
Li, X., Yuan, N., Lin, L., Yin, L., & Qu, Y. (2022). [Corrigendum] Targeting cysteine‑rich angiogenic inducer‑61 by antibody immunotherapy suppresses growth and migration of non‑small cell lung cancer. Experimental and Therapeutic Medicine, 24, 438. https://doi.org/10.3892/etm.2022.11365
MLA
Li, X., Yuan, N., Lin, L., Yin, L., Qu, Y."[Corrigendum] Targeting cysteine‑rich angiogenic inducer‑61 by antibody immunotherapy suppresses growth and migration of non‑small cell lung cancer". Experimental and Therapeutic Medicine 24.1 (2022): 438.
Chicago
Li, X., Yuan, N., Lin, L., Yin, L., Qu, Y."[Corrigendum] Targeting cysteine‑rich angiogenic inducer‑61 by antibody immunotherapy suppresses growth and migration of non‑small cell lung cancer". Experimental and Therapeutic Medicine 24, no. 1 (2022): 438. https://doi.org/10.3892/etm.2022.11365